STAT Plus: Sean Parker, billionaire and philanthropist, gets an immunotherapy company off the ground
SEPTEMBER DAWN BOTTOMS FOR STAT
ArsenalBio aims to use CRISPR, synthetic biology, and other technologies to engineer immune cell therapies that can better find and kill cancer cells.
.png)
No hay comentarios:
Publicar un comentario